What amount sold does Definition II-A LLC report in Form D filings?

The latest linked filings report $29.4M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Definition II-A LLC's most recent SEC filing?

Definition II-A LLC's most recent Form D filing was on 2026-09-01.

How many investors does Definition II-A LLC have?

The most recent Form D filing lists 12 investor(s).

Definition II-A LLC

CIK: 0002095550·Other·NEW YORK, NY·Limited Liability Company·Founded 2025

Reported Sold

$29,435,000

Total Filings

Identified Offerings

Last Filed

Sep 1, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Sep 1, 2026Form D — New notice

Reported sold: $10,150,000 · Target: $10,150,000

Rule 506(b)·12 investors

Jan 6, 2026Form D — New notice

Reported sold: $9,135,000 · Target: $9,135,000

Rule 506(b)·13 investors

Nov 7, 2025Form D — New notice

Reported sold: $10,150,000 · Target: $10,150,000

Rule 506(b)·13 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$29,435,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Weston Reynolds

Executive Officer

Appears on 2 filings

Theodore Citrin

Executive Officer

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 1, 2026	New	$10,150,000	$10,150,000	12
Jan 6, 2026	New	$9,135,000	$9,135,000	13
Nov 7, 2025	New	$10,150,000	$10,150,000	13

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Altrartis Therapeutics Inc.

Other

Offering target: $10,999,977

Filed Oct 22, 2026